or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    LBPH A Longboard Pharmaceuticals, Inc. -0.02
    SUPN B Supernus Pharmaceuticals, Inc. -0.25
    LGND C Ligand Pharmaceuticals Incorporated 5.16
    INCY C Incyte Corporation -1.49
    HCM C Hutchison China MediTech Limited -1.50
    HALO F Halozyme Therapeutics, Inc. -0.85
    BIIB F Biogen Idec Inc. 1.89
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 10.36
    PBE D PowerShares Dynamic Biotech & Genome 9.98
    PJP D PowerShares Dynamic Pharmaceuticals 9.81
    BIS B ProShares UltraShort Nasdaq Biotechnology 9.05
    XPH B SPDR S&P Pharmaceuticals ETF 8.04
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare FBT to PJP Compare PJP to BIS Compare PJP to XPH

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 HALO Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
        Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
        Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
        Nov 19 INCY Sector Update: Health Care Stocks Decline
        Nov 19 INCY Top Midday Decliners
        Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
        Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
        Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 HALO 3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
        Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
        Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
        Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
        Nov 19 HALO HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
        Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
        Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags